Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9520.
-
McLaren Resources Initiates Exploration Targeting Program on Timmins Area Gold PropertiesMcLaren Resources Inc. has launched an integrated satellite remote-sensing and predictive targeting program across its Blue Quartz, McCool, and Kerrs gold properties in Ontario.
-
Live Energy Minerals Completes Issuance of First Tranche of Shares for Plaster Rock PropertyLive Energy Minerals Corp. has issued 120,000 common shares to an arm's length optionor as the first payment under its option agreement for the Plaster Rock Property in New Brunswick.
-
Coloured Ties Capital Inc. Closes Non-Brokered Private PlacementColoured Ties Capital Inc. has successfully closed its previously announced non-brokered private placement, raising approximately $1.2 million in gross proceeds.
-
Copper Road Resources Completes Option Payments for Ben Nevis ProjectCopper Road Resources Inc. has fulfilled its latest option payment obligations for the Ben Nevis Project, ensuring the agreements remain in good standing.
-
Critical Metals Corp. Receives Supreme Court Approval for European Lithium AcquisitionThe Supreme Court of Western Australia has approved Critical Metals Corp.'s proposed acquisition of European Lithium Limited.
-
Jeremy Gillis Files Amended Early Warning Disclosure Regarding Northern Lights Resources Corp. HoldingsJeremy Gillis and joint actors issued an amended early warning report to correct previous disclosures regarding their security holdings in Northern Lights Resources Corp.
-
Maxim Group Downgrades Worksport to Hold from BuyMaxim Group has downgraded Worksport Ltd. (WKSP) from a 'Buy' rating to a 'Hold' rating.
-
Cyngn Discloses Director Resignation and Nasdaq Audit Committee Non-ComplianceDirector Karen Macleod will resign following the 2026 Annual Meeting, resulting in a temporary failure to meet Nasdaq's Audit Committee composition requirements.
-
Prospect Ridge Resources Corp. Closes Oversubscribed Private PlacementProspect Ridge Resources Corp. has successfully closed the third and final tranche of its non-brokered private placement, raising a total of $1,836,375.
-
Arrive AI Announces Date for Third Quarter 2026 Financial ResultsArrive AI Inc. has scheduled the release of its third quarter 2026 financial results for the morning of November 13, 2026.
-
Ainos Surpasses 3 Billion Real-World Chemical Data PointsAinos, Inc. announced that its AI Nose platform has reached a milestone of over 3 billion real-world chemical data points, tripling its previous milestone from September.
-
Rumbu Holdings Ltd. Announces Exercise of OptionsRumbu Holdings Ltd. announced that its directors and officers exercised options, resulting in the issuance of 650,000 common shares and $65,000 in gross proceeds.
-
Hi-View Resources Inc. to Present at 52nd Annual New Orleans Investment ConferenceHi-View Resources Inc. announced its participation in the 52nd Annual New Orleans Investment Conference, with VP of Exploration Nader Mostaghimi scheduled to present.
-
Parvis Invest Inc. Terminates FavorPoint Capital Acquisition and Reports Financial ResultsParvis Invest Inc. has terminated its agreement to acquire FavorPoint Capital, LLC to focus on its Canadian platform and reported a swing to net income for the six months ended September 30, 2026.
-
NEXE Innovations Reports Q1 Fiscal 2027 Financial Results and Business UpdateNEXE Innovations reported a 10.5% year-over-year revenue increase to $133,119 for the first quarter of fiscal 2027 and provided updates on its commercial expansion.
-
Tempest Therapeutics Appoints Stephanie Horn-Warnock as CFOTempest Therapeutics has appointed Stephanie Horn-Warnock as Chief Financial Officer, Treasurer, and Corporate Secretary following the resignation of Constance Ames.
-
Rapid Dose Therapeutics Announces Proposed Debt SettlementRapid Dose Therapeutics Corp. has entered into an agreement to issue up to 5,000,000 common shares to settle up to $500,000 in outstanding accounts payable.
-
JonesTrading Downgrades EyePoint Pharmaceuticals to HoldJonesTrading analyst Debanjana Chatterjee has downgraded EyePoint Pharmaceuticals (NASDAQ: EYPT) from a previous rating to a Hold rating.
-
MIRA Pharmaceuticals Receives DEA Determination on Drug CandidatesMIRA Pharmaceuticals announced that the U.S. Drug Enforcement Administration (DEA) has determined that its three primary drug candidates—SKNY-1, Ketamir-2, and MIRA-55—are not controlled substances.
-
Western Uranium & Vanadium Corp. Releases Annual Form 10-K ReportWestern Uranium & Vanadium Corp. has filed its annual Form 10-K, providing a comprehensive update on its financial performance, operational status, and strategic outlook.